ICT03-Es5

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameICT03-Es5
Drug Alias NameEs5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA cross linking agents
TargetsDNA
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungLiver NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Salford
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIncanthera PLC
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungLiver NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A